CN106278954A - A kind of method extracting agmatine - Google Patents

A kind of method extracting agmatine Download PDF

Info

Publication number
CN106278954A
CN106278954A CN201610684104.8A CN201610684104A CN106278954A CN 106278954 A CN106278954 A CN 106278954A CN 201610684104 A CN201610684104 A CN 201610684104A CN 106278954 A CN106278954 A CN 106278954A
Authority
CN
China
Prior art keywords
agmatine
clear liquid
method extracting
arginine
thalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610684104.8A
Other languages
Chinese (zh)
Other versions
CN106278954B (en
Inventor
李斌水
米造吉
何连顺
张学义
张玉锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JING JING PHARMACEUTICAL Co Ltd
Original Assignee
JING JING PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JING JING PHARMACEUTICAL Co Ltd filed Critical JING JING PHARMACEUTICAL Co Ltd
Priority to CN201610684104.8A priority Critical patent/CN106278954B/en
Publication of CN106278954A publication Critical patent/CN106278954A/en
Application granted granted Critical
Publication of CN106278954B publication Critical patent/CN106278954B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention discloses a kind of method extracting agmatine, relate to the extractive technique field of compound.Comprise the following steps: (1) uses raw material to be arginine, and the bioenzymatic conversion feed liquid containing agmatine produced under arginine decarboxylase effect carries out freeze thawing treatment, makes arginine decarboxylase lose biological activity;(2) take the bioenzymatic conversion feed liquid after inactivation and carry out high speed centrifugation, isolate thalline and protein matter, obtain centrifugal clear liquid;(3) centrifugal clear liquid is crossed membranous system, remove thalline relic and macromolecular substances, obtained film dialysis clear liquid;(4) concentrate crossing film dialysis clear liquid, regulate pH after activated carbon decolorizing and carry out solvent crystal, filter to obtain agmatine crude product.This method can quickly process acquisition agmatine crude product, decreases chemical reaction intermediate processing steps, decreases impurity in product, simultaneously, capacity efficiency is high, and low cost is easy and simple to handle, good product quality, improves product quality and yield, creates good economic benefit.

Description

A kind of method extracting agmatine
Technical field
The present invention relates to the extractive technique field of compound.
Background technology
Agmatine (gamatine) is the material of a multi-biological function, discharges hypothalamic hormone by stimulating Carry out work, it is possible to promoting Alfasone and growth hormone, agmatine has multiple benefits, it is possible to increase health durability degree, to motion Member and bodybuilders have certain benefit and it can be made satisfied, can accelerate physical recovery simultaneously, improve muscle quantities, reduce obesity Oils and fats, improves health performance, and to pursuing, health is dynamic and to seek each age level healthy lifestyles helpful, guanidine Base butylamine can also improve nitric oxide production content by two kinds of approach, stimulates release nitric oxide and suppression Nitric oxide syntheses Synthesis (Nitric oxide syntheses can consume nitric oxide).
Having data to show, central nervous system, gamatine can strengthen the analgesic effect of opioid drug, slow down drug resistance The generation of property and improve Acute Morphine withdrawal syndrome, gamatine can also promote consolidation of memory in addition.At cardiovascular system, Gamatine can reduce heart rate, and mean arterial pressure, left chamber pressure, peripheral vascular resistance and cardiac index etc., gamatine is also simultaneously Gastric acid and pepsic secretion can be increased, make mucosal thickness thinning, deteriorate the mucosa infection etc. that stress cause.There is research simultaneously Showing, agmatine also has the effect of clear and definite suppression tumor cell proliferation, and the effect of its suppression tumor cell proliferation has tumor Cell strain specificity.
Present stage, main by chemical synthesis acquisition gamatine on market, primary raw material has Putriscine, O-first Base isourea sulfate, sulphuric acid, alcohol etc., course of reaction energy consumption is high, and yield is low, and impurity is many, and potential safety hazard is big, has certain dirt to environment Dye;Also have employing Isosorbide-5-Nitrae-dibromobutane and potassium phthalimide is raw material simultaneously, is substituted, amine solution and guanidinated three steps Reaction prepares the report of agmatine sulfate, this route reaction mild condition, but side reaction is more, and complex operation, and abnormal smells from the patient is difficult Hearing, course of reaction uses relatively multi-solvent, does not meets the Production requirement of clean and effective.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of method extracting agmatine, and the method can quickly process and obtain Obtain agmatine crude product, relatively conventional chemical synthesis, effectively reduce chemical reaction intermediate processing steps, decrease intermediate Side reaction and during impurity, useless solvent, the generation of waste gas, meanwhile, capacity efficiency is high, and low cost is easy and simple to handle, product matter Measure, decrease impurity in product, improve product quality and yield, create good economic benefit.
For solving above-mentioned technical problem, the technical solution used in the present invention is: a kind of method extracting agmatine, including Following steps:
(1) using raw material is arginine, in the lower generation of arginine decarboxylase (arginine decarboxylase, ADC) effect The bioenzymatic conversion feed liquid containing agmatine carry out freeze thawing treatment, make arginine decarboxylase lose biological activity;
(2) take the bioenzymatic conversion feed liquid after inactivation and carry out high speed centrifugation, isolate thalline and protein matter, obtain centrifugal clear Liquid;
(3) centrifugal clear liquid is crossed membranous system, remove thalline relic and macromolecular substances, obtained film dialysis clear liquid;
(4) by cross film dialysis clear liquid concentrate, after activated carbon decolorizing regulate pH carry out solvent crystal, filter agmatine is thick Product.
Preferably, in step (1), arginine decarboxylase is the arginine decarboxylase from antibacterial or plant-derived smart ammonia Acid decarboxylase.
Preferably, in step (1), freeze thawing treatment, use-20 DEG C~5 DEG C ,-30 DEG C~10 DEG C ,-35 DEG C~20 DEG C successively Freeze thawing treatment scheme.
It is further preferred that in step (1), freeze thawing treatment, use the mode of filtration to isolate portion after dissolving for the first time Divide thalline.
Preferably, in step (2), take after the bioenzymatic conversion feed liquid after inactivation adds chelating agent or flocculant, carry out from The heart.
It is further preferred that chelating agent used or flocculant have: mercaptoethylmaine, polyacrylamide, TGA, thiourea or EDTA(ethylenediaminetetraacetic acid).
Preferably, in step (2), high speed centrifugation uses disk centrifugal separator or tube centrifuge, centrifugal rotational speed 12000~ 15000 revs/min.
Preferably, in step (2), high speed centrifugation uses stacked centrifuge, and centrifugal rotational speed is at 15000 revs/min.
Preferably, in step (3), membranous system is pottery filter membrane and ultrafilter membrane.
It is further preferred that in step (3), pottery filter sizes is 20-100 μm;Ultrafiltration uses two-stage ultrafiltering, one-level fenestra Footpath 8000-10000 dalton, secondary membrane aperture 3000-5000 dalton.
In step (3), ultrafiltration, secondary membrane aperture can also be 1500-3000 dalton;
Obtain film dialysis clear liquid after two-stage ultrafiltering, cross film dialysis clear liquid light transmittance more than 97%.
Preferably, in step (4), pH is 3.0-7.0.
Preferably, in step (4), after film dialysis clear liquid was concentrated into the 20-50% of film dialysis clear liquid original volume excessively, add Enter the medicinal carbon of agmatine quality 0.5%-3% in film dialysis clear liquid and carry out adsorption bleaching.
Preferably, in step (4), solvent is methanol, ethanol or isopropanol, and solvent consumption is that the film of crossing after regulation pH is dialysed 1.2-4.5 times of supernatant volume.
Use and have the beneficial effects that produced by technique scheme: the inventive method can quickly process acquisition agmatine Crude product, relatively conventional chemical synthesis, effectively reduce chemical reaction intermediate processing steps, decrease intermediate side reaction and During impurity, useless solvent, the generation of waste gas, meanwhile, capacity efficiency is high, and low cost is easy and simple to handle, good product quality, subtracts Lack impurity in product, improve product quality and yield, create good economic benefit.
Detailed description of the invention
Below in conjunction with detailed description of the invention, the present invention is further detailed explanation.
Embodiment 1
(1) using raw material is arginine, arginine decarboxylase (arginine decarboxylase is the arginine decarboxylase from antibacterial) Lower bioenzymatic conversion feed liquid 500L containing agmatine 105kg produced of effect is placed in freeze dryer distributor pipe, carries out at freeze thawing Reason, fast cooling is incubated 1 hour to-20 DEG C, is rapidly heated to 5 DEG C, is directly placed in centrifuge by the liquid in distributor pipe, gets rid of Filter cutting out partial thalline;Liquid rejection filter gone out the most averagely imports in freeze dryer distributor pipe, fast cooling to-30 DEG C of insulations It is warming up to 10 DEG C after 1 hour again, is cooled to-35 DEG C in the same way and rises again again to 20 DEG C.
(2) the bioenzymatic conversion feed liquid (freeze thawing inactivation) that will rise again, adds the chelating agent of bioenzymatic conversion feed liquid quality 2%, Slowly putting into disk centrifugal separator after stirring 1 hour, centrifugal rotational speed, at 12000~15000 revs/min, is isolated thalline, is adopted continuously Go out clear liquid, obtain centrifugal clear liquid 470L.
(3) above-mentioned clear liquid 470L carries out pottery filter, and pottery filter sizes is 20-100 μm;Ultrafiltration uses two-stage ultrafiltering, one-level Membrane aperture 8000-10000 dalton, secondary membrane aperture 3000-5000 dalton, two-stage ultrafiltering, after terminating, use 50L purified water Washing membranous system, obtained film dialysis clear liquid 500L, detected agmatine content 193g/L, yield 92.3%, crossed film dialysis clear liquid printing opacity Rate is more than 97%.
(4) take above-mentioned cross film dialysis clear liquid 500L be concentrated into film dialysis clear liquid original volume 50% after, add 3kg activity Charcoal adsorption bleaching, after filtration, regulates pH to 5.0, adds 500L isopropanol and separates out crystal, filter to obtain agmatine in gained feed liquid Crude product, 65 DEG C of vacuum is dried, detects moisture 0.26%, pure 90.22kg, yield 93.5%.
Embodiment 2
(1) using raw material is arginine, and at arginine decarboxylase, (arginine decarboxylase is from plant-derived arginine decarboxylation Enzyme) act on and descend the bioenzymatic conversion feed liquid containing agmatine produced to carry out freeze thawing treatment, make arginine decarboxylase lose biology Activity.Freeze dryer distributor pipe 80 is cooled to-20 DEG C, in every distributor pipe, adds 5L bioenzymatic conversion feed liquid, constant temperature-20 DEG C insulation 1 hour, be rapidly heated to 5 DEG C, the liquid in distributor pipe be directly placed in centrifuge, rejection filter cutting out partial thalline Amount to 4.6kg;Liquid rejection filter gone out the most averagely imports in distributor pipe, and fast cooling heats up after being incubated 1 hour to-30 DEG C again To 10 DEG C, be cooled to-35 DEG C in the same way and rise again again to 20 DEG C.
(2) the bioenzymatic conversion feed liquid (freeze thawing inactivation) that will rise again, the bioenzymatic conversion feed liquid quality 3% that addition is risen again Chelating agent, slowly puts into disk centrifugal separator after stirring 1 hour, and centrifugal rotational speed, at 12000~15000 revs/min, isolates bacterium Body, continuous extraction clear liquid, obtain centrifugal clear liquid 355L.
(3) above-mentioned clear liquid 355L carries out pottery filter, and pottery filter sizes is 20-100 μm;Ultrafiltration uses two-stage ultrafiltering, one-level Membrane aperture 8000-10000 dalton, secondary membrane aperture 3000-5000 dalton, two-stage ultrafiltering, after terminating, use 50L purified water Washing membranous system, obtained film dialysis clear liquid 400L, detected agmatine content 190.2g/L, yield 90.5%, crossed film dialysis clear liquid saturating Light rate is more than 97%.
(4) take the above-mentioned film dialysis clear liquid 400L that crosses and be concentrated into the 40% of film dialysis clear liquid original volume, add 2kg activated carbon Adsorption bleaching, after filtration, regulates pH to 6.0, and the ethanol 500L adding volume fraction 95% in gained feed liquid separates out crystal, mistake Filter to obtain agmatine crude product, pure 69.3kg, yield 91.2%.
Embodiment 3
(1) using raw material is arginine, arginine decarboxylase (arginine decarboxylase is the arginine decarboxylase from antibacterial) Lower bioenzymatic conversion feed liquid 800L containing agmatine produced of effect is placed in freeze dryer distributor pipe, carries out freeze thawing treatment, soon Speed is cooled to-20 DEG C and is incubated 1 hour, is rapidly heated to 5 DEG C, is directly placed in centrifuge by the liquid in distributor pipe, and rejection filter is divided Separate out part thalline;Liquid rejection filter gone out the most averagely imports in distributor pipe, fast cooling to-30 DEG C insulation 1 hour after again It is warming up to 10 DEG C, is cooled to-35 DEG C in the same way and rises again again to 20 DEG C.
(2) the bioenzymatic conversion feed liquid (freeze thawing inactivation) that will rise again, adds the bioenzymatic conversion feed liquid quality 2.5% risen again Flocculant, slowly put into tube centrifuge after stirring 1 hour, centrifugal rotational speed, at 12000~15000 revs/min, isolates bacterium Body, continuous extraction clear liquid, obtain centrifugal clear liquid 760L.
(3) above-mentioned centrifugal clear liquid 760L carries out pottery filter, and pottery filter sizes is 20-100 μm;Ultrafiltration uses two-stage ultrafiltering, One-level membrane aperture 8000-10000 dalton, secondary membrane aperture 3000-5000 dalton, two-stage ultrafiltering is after terminating, pure with 50L Change water washing membranous system, obtained film dialysis clear liquid 805L, and detected agmatine content 184.34g/L, yield 92.3%, and crossed film dialysis Clear liquid light transmittance is more than 97%.
(4) take the above-mentioned film dialysis clear liquid 400L that crosses and be concentrated into the 50% of film dialysis clear liquid original volume, add 2kg activated carbon Adsorption bleaching, after filtration, regulates pH to 4.5, and the ethanol 500L adding volume fraction 95% in gained feed liquid separates out crystal, mistake Filtering to obtain agmatine crude product, 60 DEG C of vacuum is dried, detects moisture 0.3%, obtains the pure 67.1kg of agmatine crude product, yield 91.0%.

Claims (10)

1. the method extracting agmatine, it is characterised in that: comprise the following steps:
(1) using raw material is arginine, the bioenzymatic conversion feed liquid containing agmatine produced under arginine decarboxylase effect Carry out freeze thawing treatment, make arginine decarboxylase lose biological activity;
(2) take the bioenzymatic conversion feed liquid after inactivation and carry out high speed centrifugation, isolate thalline and protein matter, obtain centrifugal clear Liquid;
(3) centrifugal clear liquid is crossed membranous system, remove thalline relic and macromolecular substances, obtained film dialysis clear liquid;
(4) by cross film dialysis clear liquid concentrate, after activated carbon decolorizing regulate pH carry out solvent crystal, filter agmatine is thick Product.
A kind of method extracting agmatine the most according to claim 1, it is characterised in that: in step (1), arginine decarboxylation Enzyme is the arginine decarboxylase from antibacterial or plant-derived arginine decarboxylase.
A kind of method extracting agmatine the most according to claim 1, it is characterised in that: in step (1), freeze thawing treatment, Use-20 DEG C~5 DEG C ,-30 DEG C~the freeze thawing treatment scheme of 10 DEG C ,-35 DEG C~20 DEG C successively.
A kind of method extracting agmatine the most according to claim 3, it is characterised in that: in step (1), freeze thawing treatment, The mode cutting out partial thalline of filtration is used after dissolving for the first time.
A kind of method extracting agmatine the most according to claim 1, it is characterised in that: in step (2), after taking inactivation After bioenzymatic conversion feed liquid adds chelating agent or flocculant, it is centrifuged.
A kind of method extracting agmatine the most according to claim 1, it is characterised in that: in step (2), high speed centrifugation is adopted With disk centrifugal separator or tube centrifuge, centrifugal rotational speed is at 12000~15000 revs/min.
A kind of method extracting agmatine the most according to claim 1, it is characterised in that: in step (3), membranous system is pottery Filter membrane and ultrafilter membrane.
A kind of method extracting agmatine the most according to claim 7, it is characterised in that: in step (3), filter sizes of making pottery For 20-100 μm;Ultrafiltration uses two-stage ultrafiltering, one-level membrane aperture 8000-10000 dalton, 3000-5000 road, secondary membrane aperture Er Dun.
A kind of method extracting agmatine the most according to claim 1, it is characterised in that in step (4), pH is 3.0- 7.0。
A kind of method extracting agmatine the most according to claim 1, it is characterised in that in step (4), solvent is first Alcohol, ethanol or isopropanol.
CN201610684104.8A 2016-08-18 2016-08-18 A kind of method for extracting agmatine Active CN106278954B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610684104.8A CN106278954B (en) 2016-08-18 2016-08-18 A kind of method for extracting agmatine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610684104.8A CN106278954B (en) 2016-08-18 2016-08-18 A kind of method for extracting agmatine

Publications (2)

Publication Number Publication Date
CN106278954A true CN106278954A (en) 2017-01-04
CN106278954B CN106278954B (en) 2018-06-01

Family

ID=57679754

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610684104.8A Active CN106278954B (en) 2016-08-18 2016-08-18 A kind of method for extracting agmatine

Country Status (1)

Country Link
CN (1) CN106278954B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114058651A (en) * 2021-09-30 2022-02-18 新泰市佳禾生物科技有限公司 Preparation method of agmatine

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1260588A2 (en) * 2001-05-25 2002-11-27 Ajinomoto Co., Ltd. Methods of producing agmatine and arginine decarboxylase
EP1270552A2 (en) * 2001-05-25 2003-01-02 Ajinomoto Co., Inc. Production process for a guanidine derivative containing an amido group and for a salt thereof
CN104152478A (en) * 2014-07-31 2014-11-19 洛阳华荣生物技术有限公司 Method for coproducing D-arginine and gamatine through biotransformation
CN105861529A (en) * 2016-05-27 2016-08-17 江南大学 Arginine decarboxylase and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1260588A2 (en) * 2001-05-25 2002-11-27 Ajinomoto Co., Ltd. Methods of producing agmatine and arginine decarboxylase
EP1270552A2 (en) * 2001-05-25 2003-01-02 Ajinomoto Co., Inc. Production process for a guanidine derivative containing an amido group and for a salt thereof
CN104152478A (en) * 2014-07-31 2014-11-19 洛阳华荣生物技术有限公司 Method for coproducing D-arginine and gamatine through biotransformation
CN105861529A (en) * 2016-05-27 2016-08-17 江南大学 Arginine decarboxylase and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SUN XIA等: ""Enzymatic production of agmatine by recombinant arginine decarboxylase"", 《JOURNAL OF MOLECULAR CATALYSIS B: ENZYMATIC》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114058651A (en) * 2021-09-30 2022-02-18 新泰市佳禾生物科技有限公司 Preparation method of agmatine

Also Published As

Publication number Publication date
CN106278954B (en) 2018-06-01

Similar Documents

Publication Publication Date Title
CN101838200B (en) Method for extracting and separating chlorogenic acid from honeysuckle
CN101798355B (en) Method for integrated separation and extraction of tea polysaccharide, theanine, polyphenol and caffeine
CN112521523B (en) Method for extracting and purifying inonotus obliquus polysaccharide
CN102351917A (en) Method for extracting raffinose from cotton seed meal
CN102807511B (en) Method for extracting taurine from mussel
CN101880245A (en) Method for purifying citrulline from watermelon
CN105039480A (en) Method for purifying collagen derived from pelodiscus sinensis
CN102286591A (en) Preparation method yeast resource active polypeptide
CN105274179A (en) Process for extracting L-isoleucine
CN106278954A (en) A kind of method extracting agmatine
CN101337921B (en) Method for preparing 5-hydroxytryptamine from hippophae rhamnoides
CN104119229A (en) Technology for producing pure chlorogenic acid
CN103232354A (en) Method for separating heteroacid from valine fermentation liquid
CN102432573B (en) Method for preparing lovastatin
CN104558227A (en) Method for extracting ganoderan
CN107473979A (en) A kind of processing method of film extraction theanine
CN110963933A (en) Process for extracting and purifying gamma-aminobutyric acid from tea
CN106834399A (en) A kind of Antihypertensive Peptides from Trachyostracous mussel closed shell flesh
CN1028225C (en) New process for extracting levodopa by use of water percolation-ion exchange method
CN105566404A (en) N-acetyl neuraminic acid dry powder preparation method using technologies of microbial fermentation broth separation and purification and spray-drying
CN106699834A (en) Method for extracting momordica glycosides from momordica grosvenori
CN101780134B (en) Membrane separation process for extracting solution of south dodder seed
CN108658919A (en) The method for purifying and separating of Akebia trifoliate koiaz Peels flavones
CN108424468A (en) A kind of preparation process of abalone polysaccharide
CN107698692A (en) A kind of extracting method of astragalus polyose

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A Method of Extracting Agmatine

Effective date of registration: 20221010

Granted publication date: 20180601

Pledgee: Ningjin Sub branch of Xingtai Bank Co.,Ltd.

Pledgor: JING JING PHARMACEUTICAL Co.,Ltd.

Registration number: Y2022130000091

PE01 Entry into force of the registration of the contract for pledge of patent right
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20230921

Granted publication date: 20180601

Pledgee: Ningjin Sub branch of Xingtai Bank Co.,Ltd.

Pledgor: JING JING PHARMACEUTICAL Co.,Ltd.

Registration number: Y2022130000091

PC01 Cancellation of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A Method for Extracting Agmatine

Effective date of registration: 20230922

Granted publication date: 20180601

Pledgee: Ningjin Sub branch of Xingtai Bank Co.,Ltd.

Pledgor: JING JING PHARMACEUTICAL Co.,Ltd.

Registration number: Y2023980058579

PE01 Entry into force of the registration of the contract for pledge of patent right